Pharmafile Logo
Pharmafocus logo
Advanced Search

BenevolentAI

Showing 4 posts of 4 posts found.

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024
Research and Development AstraZeneca, BenevolentAI, Cardiology, collaboration, heart failure

BenevolentAI has announced that AstraZeneca has added a novel heart failure target to its discovery portfolio following the two companies’ …

News

BenevolentAI appoints Dr Joerg Moeller as CEO

January 25, 2024
Business Services BenevolentAI, CEO, Dr Joerg Moeller, appointment

BenevolentAI has announced that it has appointed Dr Joerg Moeller MD PhD as chief executive officer and executive board member …

Appointment
joanna_shields

BenevolentAI names former UK Minister as new Group CEO

May 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, BenevolentAI, Facebook, UK, appointment, google

Health and drug development-focused artificial intelligence firm BenevolentAI has announced that former UK Minister for Internet Security and Safety Joanna …

Appointment
8384110298_da510e0347_c

BenevolentAI financing round takes valuation to $2bn+

April 19, 2018
Medical Communications BenevolentAI, biotech, drugs, pharma, pharmaceutical

BenevolentAI, a London based drug discovery biotech, has revealed that a $115 million financing round now sees the company valued …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026